| Elective cancer surgery in COVID-19–free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study JC Glasbey, D Nepogodiev, JFF Simoes, O Omar, E Li, ML Venn, ... Journal of Clinical Oncology 39 (1), 66, 2021 | 251 | 2021 |
| Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, CY Hsu, ... Annals of oncology 32 (6), 787-800, 2021 | 243 | 2021 |
| Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19 MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ... JAMA oncology 7 (8), 1167-1175, 2021 | 165 | 2021 |
| Cellular heterogeneity profiling by hyaluronan probes reveals an invasive but slow-growing breast tumor subset M Veiseh, DH Kwon, AD Borowsky, C Tolg, HS Leong, JD Lewis, ... Proceedings of the National Academy of Sciences 111 (17), E1731-E1739, 2014 | 63 | 2014 |
| Racial disparities in COVID-19 outcomes among black and white patients with cancer J Fu, SA Reid, B French, C Hennessy, C Hwang, NT Gatson, N Duma, ... JAMA network open 5 (3), e224304-e224304, 2022 | 40 | 2022 |
| Ethnic disparities among men with prostate cancer undergoing germline testing DHM Kwon, HT Borno, HH Cheng, AY Zhou, EJ Small Urologic Oncology: Seminars and Original Investigations 38 (3), 80. e1-80. e7, 2020 | 40 | 2020 |
| Association between androgen deprivation therapy and mortality among patients with prostate cancer and COVID-19 AL Schmidt, MD Tucker, Z Bakouny, C Labaki, CY Hsu, Y Shyr, ... JAMA network open 4 (11), e2134330-e2134330, 2021 | 36 | 2021 |
| TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor I de Kouchkovsky, L Zhang, EJ Philip, F Wright, DM Kim, D Natesan, ... Journal for immunotherapy of cancer 9 (5), 2021 | 26 | 2021 |
| Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working group V Narayan, M Harrison, H Cheng, S Kenfield, R Aggarwal, D Kwon, ... Urologic Oncology: Seminars and Original Investigations 38 (3), 83-93, 2020 | 26 | 2020 |
| Immunogenic priming with 177Lu-PSMA-617 plus pembrolizumab in metastatic castration resistant prostate cancer (mCRPC): A phase 1b study. RR Aggarwal, S Luch Sam, VS Koshkin, EJ Small, FY Feng, ... Journal of Clinical Oncology 39 (15_suppl), 5053-5053, 2021 | 24 | 2021 |
| Changes in cancer management due to COVID-19 illness in patients with cancer in Northern California JTY Wu, DH Kwon, MJ Glover, S Henry, D Wood, DL Rubin, VS Koshkin, ... JCO oncology practice 17 (3), e377-e385, 2021 | 20 | 2021 |
| Androgen-deprivation therapy and SARS-CoV-2 in men with prostate cancer: findings from the University of California Health System registry DH Kwon, R Vashisht, HT Borno, RR Aggarwal, EJ Small, AJ Butte, ... Annals of Oncology 32 (5), 678-679, 2021 | 17 | 2021 |
| Periprocedural management of patients undergoing liver resection or embolotherapy for neuroendocrine tumor metastases DH Kwon, A Paciorek, CK Mulvey, H Chan, N Fidelman, L Meng, ... Pancreas 48 (4), 496-503, 2019 | 17 | 2019 |
| Physician‐reported barriers to referring cancer patients to specialists: Prevalence, factors, and association with career satisfaction DH Kwon, DM Tisnado, NL Keating, CN Klabunde, JL Adams, A Rastegar, ... Cancer 121 (1), 113-122, 2015 | 17 | 2015 |
| Interplay of immunosuppression and immunotherapy among patients with cancer and COVID-19 Z Bakouny, C Labaki, P Grover, J Awosika, S Gulati, CY Hsu, ... JAMA oncology 9 (1), 128-134, 2023 | 15 | 2023 |
| Differential treatment outcomes in BRCA1/2‐, CDK12‐, and ATM‐mutated metastatic castration‐resistant prostate cancer DH Kwon, J Chou, SM Yip, MA Reimers, L Zhang, F Wright, MS Dhawan, ... Cancer 127 (12), 1965-1973, 2021 | 13 | 2021 |
| Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19 SM Rubinstein, D Bhutani, RC Lynch, CY Hsu, Y Shyr, S Advani, ... Blood cancer discovery 3 (3), 181-193, 2022 | 12 | 2022 |
| Gastric neuroendocrine tumors: management and challenges DH Kwon, EK Nakakura, EK Bergsland, SC Dai Gastrointestinal Cancer: Targets and Therapy, 31-37, 2017 | 12 | 2017 |
| Coinfections in patients with cancer and COVID-19: a COVID-19 and cancer consortium (CCC19) study G Satyanarayana, KT Enriquez, T Sun, EJ Klein, M Abidi, SM Advani, ... Open forum infectious diseases 9 (3), ofac037, 2022 | 10 | 2022 |
| The impact of androgen deprivation therapy on COVID-19 illness in men with prostate cancer NJ Shah, VG Patel, X Zhong, L Pina, JE Hawley, E Lin, BA Gartrell, ... JNCI cancer spectrum 6 (3), pkac035, 2022 | 9 | 2022 |
